Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹14Cr
Rev Gr TTM
Revenue Growth TTM
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

AROMAENT
VS
| Quarter | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|
|
Growth YoY Revenue Growth YoY% | -100.0 | | | | | | | | | | | |
| 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Profit Operating ProfitCr |
| | | | | | | | | | | | |
Other Income Other IncomeCr | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | -58.0 | 19.2 | 6.3 | 42.1 | -91.1 | 233.3 | 210.0 | 254.6 | -185.7 | -110.7 | -103.0 | -102.9 |
| | | | | | | | | | | | |
| 1.6 | -0.4 | -0.6 | -0.5 | 0.1 | 0.6 | 0.7 | 0.7 | -0.1 | -0.1 | 0.0 | 0.0 |
| Financial Year | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|
|
| | | 1,356.8 | 52.2 | 5.0 | -12.7 | -79.7 | -100.0 | | | |
| 0 | 1 | 24 | 47 | 37 | 34 | 13 | 4 | 2 | 0 | 0 |
Operating Profit Operating ProfitCr |
| | 41.6 | 2.8 | -22.9 | 8.4 | 1.7 | -82.7 | | | | |
Other Income Other IncomeCr | 1 | 0 | 0 | 3 | 0 | 0 | 1 | 4 | 1 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 1 | 1 | -6 | 2 | 0 | -5 | 0 | -1 | 0 | 0 |
| 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| | -29.9 | 64.8 | -1,434.2 | 129.2 | -91.8 | -3,069.3 | 96.2 | -276.0 | 56.7 | 62.3 |
| | 17.2 | 1.9 | -17.1 | 4.8 | 0.5 | -65.7 | | | | |
| 0.9 | 0.6 | 1.0 | -13.4 | 3.9 | 0.3 | -9.4 | -0.4 | -1.4 | -0.6 | -0.2 |
| Financial Year | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 |
|---|
Equity Capital Equity CapitalCr | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| 3 | 3 | 4 | -3 | -1 | -1 | -6 | -6 | -6 | -7 | -7 |
Current Liabilities Current LiabilitiesCr | 0 | 1 | 8 | 19 | 14 | 33 | 34 | 32 | 34 | 31 | 31 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 0 | 1 | 10 | 23 | 17 | 36 | 33 | 30 | 32 | 29 | 29 |
Non Current Assets Non Current AssetsCr | 8 | 8 | 7 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|
Operating Cash Flow Operating Cash FlowCr | 0 | 1 | 1 | -2 | 3 | 0 | -2 | -1 | -3 | 1 |
Investing Cash Flow Investing Cash FlowCr | 0 | 1 | -1 | 0 | -1 | 0 | 1 | 1 | 1 | 0 |
Financing Cash Flow Financing Cash FlowCr | 0 | -1 | 0 | 4 | -4 | 0 | 0 | 0 | 1 | -1 |
|
Free Cash Flow Free Cash FlowCr | 0 | 0 | 1 | -2 | 3 | 0 | -2 | -1 | -3 | 1 |
| -101.2 | 200.0 | 114.1 | 31.4 | 175.2 | -70.8 | 38.8 | 546.2 | 408.7 | -383.2 |
CFO To EBITDA CFO To EBITDA% | 1,104.2 | 82.9 | 80.2 | 23.4 | 99.4 | -18.9 | 30.8 | 27.6 | 135.8 | -477.2 |
| Financial Year | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 10 | 6 | 10 | 21 | 23 | 0 | 0 | 11 | 8 | 0 |
Price To Earnings Price To Earnings | 23.3 | 21.7 | 20.2 | 0.0 | 12.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Price To Sales Price To Sales | | 3.7 | 0.4 | 0.5 | 0.6 | 0.0 | 0.0 | | | |
Price To Book Price To Book | 1.3 | 0.8 | 1.2 | 10.4 | 5.9 | 0.0 | 0.0 | -14.3 | -5.8 | 0.0 |
| -254.3 | 8.3 | 13.9 | -2.6 | 8.3 | 9.0 | -1.0 | -4.6 | -7.4 | -23.4 |
Profitability Ratios Profitability Ratios |
| | 86.0 | 25.8 | -2.4 | 37.1 | 44.6 | 62.6 | | | |
| | 41.6 | 2.8 | -22.9 | 8.4 | 1.7 | -82.7 | | | |
| | 17.2 | 1.9 | -17.1 | 4.8 | 0.5 | -65.7 | | | |
| 7.8 | 8.5 | 8.3 | -97.0 | 35.4 | 3.6 | -86.1 | -3.4 | -11.6 | -6.8 |
| 5.5 | 3.7 | 5.7 | -326.1 | 48.8 | 3.9 | 779.7 | 23.1 | 46.5 | 16.8 |
| 5.0 | 3.3 | 3.0 | -26.6 | 10.3 | 0.4 | -13.8 | -0.6 | -2.1 | -1.0 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Aroma Enterprises (India) Limited is an Ahmedabad-based enterprise primarily engaged in the trading and distribution of tobacco products and industrial commodities. Listed on the **Bombay Stock Exchange (BSE)**, the company operates as a commission agent and trader, leveraging a leadership team with over **26 years** of specialized experience in the tobacco sector. While the company maintains a proprietary cigarette brand, it currently faces significant financial and regulatory headwinds that have impacted its operational stability.
---
### **Core Business Operations and Product Portfolio**
The company’s revenue model is built on a dual-track trading strategy, focusing on high-volume consumer goods and essential industrial energy sources.
* **Tobacco and Cigarette Trading:** The company engages in the buying, selling, and distribution of cigarettes under its proprietary brand name, **'One & Only'**. It operates as a **Commission Agent**, facilitating product movement within the domestic market.
* **Industrial Commodities (Coal):** Beyond tobacco, the company is involved in the **commissioning of Coal**, serving the energy requirements of industrial clients.
* **Market Positioning:** The company operates within a **Single Segment** framework. Its strategy is heavily influenced by the **Asia Pacific** region, which remains the largest global market for tobacco, driven by rising disposable incomes and evolving social factors.
* **Proprietary Brand Strategy:** Management continues to invest in marketing and personnel to support the **'One & Only'** brand, despite stiff competition from established global and domestic tobacco giants.
---
### **Industry Context and Macro Dynamics**
Aroma Enterprises operates within the Indian tobacco ecosystem, a sector characterized by significant export contributions and defensive investment traits.
* **Global Export Powerhouse:** India is the **second-largest exporter** of tobacco globally, representing **6% of world trade volume**. Approximately **80-85%** of these exports are **Flue-Cured Virginia (FCV)** tobacco.
* **Economic Contribution:** The sector generates approximately **₹6,000 crore** in annual foreign exchange for the Indian economy.
* **Investment Characteristics:** Tobacco stocks are traditionally viewed as a **Defensive Asset Class**, noted for **low betas** (below market average) and high **Price Stability**, though they require disciplined management of debt and regulatory shifts.
* **Global Product Trends:** The company monitors global demand across three primary categories: **Virginia (flue-cured)**, **American Blend**, and **Dark/Oriental cigarettes**.
---
### **Capital Structure and Equity Profile**
The company maintains a straightforward equity-based capital structure, though its ability to leverage this capital is currently constrained by regulatory suspensions.
| Capital Category | Value (INR) | Details |
| :--- | :--- | :--- |
| **Authorized Share Capital** | **7,50,00,000** | **75,00,000** shares of **Rs. 10** each |
| **Issued Share Capital** | **5,00,00,000** | **50,00,000** shares of **Rs. 10** each |
| **Paid-Up Share Capital** | **4,94,04,000** | **4,94,04,00** shares of **Rs. 10** each |
* **Debt Status:** The company reports having **no debentures** or issued debt securities. However, it carries significant total borrowings (detailed in the risk section).
* **Credit Rating:** There is currently **no credit rating** assigned, as the company has not raised new loans or issued securities requiring formal evaluation in the recent period.
* **Dividend Policy:** No dividends were recommended for the most recent period, as the company prioritizes liquidity and the absorption of accumulated losses.
---
### **Critical Risk Factors and "Going Concern" Uncertainty**
The company is currently navigating a period of extreme financial distress, leading auditors to issue a **Going Concern** warning.
* **Accumulated Losses:** As of **December 31, 2023**, accumulated losses reached **Rs. 6,72,59,967**, significantly eroding the net worth.
* **Unrecoverable Related Party Advances:** A major point of contention is **Rs. 19,59,28,661** receivable from related parties as purchase advances. These have been outstanding for over **six months** with no active business from the counterparty. Auditors classify these as **doubtful and unrecoverable**, though management disputes this, citing **COVID-19** delays.
* **Bank Attachments and Tax Liabilities:** Statutory authorities have placed **Bank Attachments** on company accounts for tax dues totaling **Rs. 81,14,81,576** (including interest).
* **Environmental and Regulatory Risks:** Tobacco cultivation is linked to **deforestation** and **soil nutrient depletion**. Furthermore, high tax rates in the sector encourage **illegal trade and smuggling**, which pressures legitimate trading margins.
---
### **Regulatory Non-Compliance and BSE Status**
Aroma Enterprises is currently facing severe disciplinary actions from regulators and market exchanges.
* **BSE Trading Suspension:** Trading of the company’s shares is **suspended** on the **Bombay Stock Exchange** due to the non-payment of listing fees for **FY 2021-22** and **FY 2022-23**.
* **Statutory Defaults:** As of **December 31, 2023**, **Rs. 11,83,12,105** in statutory dues (including **GST, TDS, PF, and ESI**) remained pending for more than six months.
* **E-voting and Depository Failures:** In **September 2023**, the company failed to facilitate e-voting for shareholders because it had not cleared dues with the **Depository**, preventing the release of the beneficial position (**benpose**).
* **Filing Lapses:** The company failed to file audited financial statements with the **MCA** for **FY 2021-22** and missed multiple **SEBI** filing timelines (Regulation 31 and 76) throughout **2022**.
---
### **Comparative Financial Performance**
The following table summarizes the recent financial trajectory of the company:
| Financial Metric | As at March 31, 2023 | As at March 31, 2022 |
| :--- | :--- | :--- |
| **Total Borrowings (Rs. in Lacs)** | **595.18** | **707.24** |
| **Net Loss for the Year (Rs.)** | **29,18,829** | *Not Specified* |
| **Accumulated Losses (Rs.)** | **6,68,31,015** | *Not Specified* |
| **Statutory Dues Overdue (Rs.)** | **11,83,12,105** | *Not Specified* |
### **Management Outlook and Recovery Strategy**
Despite the "Going Concern" warning, management, led by **Mr. Snehal Patel**, maintains an optimistic stance on recovery. The company is currently operating under an **"extremely cost-conscious"** culture to mitigate inflationary pressures and liquidity constraints. The recovery strategy hinges on the **'Cigarette Market Forecast 2023-2028'**, which predicts steady demand in the **Asia Pacific** region. Management asserts that the **Rs. 19.59 Cr** in advances remains fully recoverable and that the company will successfully generate future business as market conditions stabilize.